Selvita

Overview

Selvita is an integrated contract research organization (CRO) providing end-to-end drug discovery and development services. The company bridges early discovery through clinical development with expertise spanning multiple therapeutic areas and operations compliant with GMP and GLP standards.

Drug Discovery Services

Selvita offers comprehensive drug discovery services from target validation to preclinical candidate nomination. The company supports a wide range of modalities, including:

• Small molecules
• Antibodies
• Protein degraders

Key expertise areas include:

• Computer-Aided Drug Design (CADD) and AI: AI-based virtual screening, structure-based drug design, structure-based virtual screening, and bioinformatics
• Chemistry: Scale-up and process chemistry, solid state characterization
• Protein Sciences: Protein production and expression
• Pharmacology: In vitro and ex vivo pharmacology, in vivo pharmacology and toxicology
• Drug Metabolism and Pharmacokinetics (DMPK)
• Omics Hub

Therapeutic area expertise includes oncology, fibrosis, respiratory diseases, neuroscience, metabolic disorders, infectious diseases, gastrointestinal diseases, immunology, and healthy aging.

Drug Development Services

Selvita provides extensive drug development and regulatory support for both small and large molecules, including:

• Analytical Support: CMC analytical support, analytical methods development and validation, impurities identification, quality control and QP release
• Formulation Development
• Stability Studies
• Microbiology Services
• Clinical Supply GMP Manufacturing
• Bioanalysis of Small Molecules
• Packaging Materials: Extractables and leachables testing, packaging functionality assessment, pharmaceutical PFAS testing
• Regulatory Affairs Support

Regulatory Compliance

Operations adhere to the highest quality standards under GMP and GLP regulations, ensuring scientific consistency, data quality, and global compliance throughout development programs.